Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Healthcare

Ontrak Files for Chapter 7 Bankruptcy: Shareholders Face Total Loss

Felix Baarz by Felix Baarz
August 31, 2025
in Healthcare, Penny Stocks, Turnaround
0
Ontrak Stock
0
SHARES
281
VIEWS
Share on FacebookShare on Twitter

The final chapter has been written for behavioral healthcare company Ontrak, which formally filed for Chapter 7 bankruptcy on August 28, 2025. This action initiates a complete court-supervised liquidation of the company, resulting in a total loss for equity holders.

Operational Collapse Precedes Bankruptcy Filing

Ontrak’s downfall accelerated rapidly in the latter half of 2025. The company’s board unanimously approved a voluntary Chapter 7 petition and subsequently resigned en masse. This decision followed the complete cessation of all business operations on July 31, 2025, when Ontrak terminated its entire workforce after determining it could no longer meet financial covenants or secure necessary funding.

The critical blow came on July 2, 2025, when a major potential client terminated its partnership agreement. This lost contract represented access to approximately 29,000 insured members and would have provided crucial revenue that might have sustained operations.

Financial Metrics Signal Deepening Crisis

Ontrak’s financial deterioration was severe and persistent throughout 2024 and into 2025:

Should investors sell immediately? Or is it worth buying Ontrak?

  • Cash depletion: The company’s liquidity position weakened dramatically, with cash reserves plummeting 41% from $9.7 million at year-end 2023 to just $5.7 million by the conclusion of 2024.
  • Revenue decline: Full-year 2024 revenue decreased by 15% to $10.8 million, accompanied by a substantial net loss of $25.5 million.
  • Q1 2025 performance: The negative trend intensified with revenue collapsing by 25% to merely $2.0 million for the first quarter.

Delisting and Failed Capital Raise

NASDAQ suspended trading of Ontrak shares on August 18, 2025, citing the company’s persistent failure to maintain the minimum $1 bid price requirement. The exchange classified Ontrak as a “Public Shell” and proceeded with delisting, a move the company did not contest. Ontrak had already been removed from the NASDAQ Composite Index on August 14 and the S&P TMI Index on August 20, with any remaining trading occurring only in the over-the-counter market.

Even a last-ditch financing effort proved insufficient to avert collapse. In late June 2025, Ontrak raised approximately $4 million through a combined stock and warrant offering, netting about $3.2 million after expenses. These funds were ultimately inadequate to address the company’s operational challenges and mounting losses.

Key Events Summary

  • Business operations ceased: July 31, 2025
  • Chapter 7 bankruptcy filed: August 28, 2025
  • NASDAQ delisting: Trading suspension implemented August 18, 2025
  • Major client loss: Affected potential enrollment of 29,000 insured members
  • Liquidity decline: 41% reduction in cash reserves during 2024

The sequence of events—from the failed client partnership and insufficient capital raise to the delisting and final bankruptcy filing—illustrates the rapid and irreversible nature of Ontrak’s decline, highlighting the intense competitive pressures within the healthcare technology sector.

Ad

Ontrak Stock: Buy or Sell?! New Ontrak Analysis from February 7 delivers the answer:

The latest Ontrak figures speak for themselves: Urgent action needed for Ontrak investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Ontrak: Buy or sell? Read more here...

Tags: Ontrak
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Conduent Stock
Cyber Security

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

February 7, 2026
Next Post
P3 Health Partners Stock

P3 Health Partners: Navigating Debt Pressures Amid Technical Buying Signals

Uranium Energy Stock

Uranium Energy Poised for Growth as US Policy Shifts Nuclear Fuel Strategy

Eastern Bankshares Stock

Eastern Bankshares Gains Momentum from Triple Catalysts

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com